Tower Research Capital (TRC)’s Lunai Bioworks Inc. Common Stock RENB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.2K | Buy |
56,166
+40,090
| +249% | +$11.6K | ﹤0.01% | 3791 |
|
2025
Q1 | $8.73K | Buy |
16,076
+3,852
| +32% | +$2.09K | ﹤0.01% | 3856 |
|
2024
Q4 | $10.2K | Sell |
12,224
-4,310
| -26% | -$3.6K | ﹤0.01% | 3827 |
|
2024
Q3 | $7.99K | Buy |
+16,534
| New | +$7.99K | ﹤0.01% | 3991 |
|
2023
Q2 | – | Sell |
-10,543
| Closed | -$10K | – | 6286 |
|
2023
Q1 | $10K | Buy |
10,543
+2,863
| +37% | +$2.72K | ﹤0.01% | 4397 |
|
2022
Q4 | $8K | Buy |
7,680
+3,196
| +71% | +$3.33K | ﹤0.01% | 4446 |
|
2022
Q3 | $8K | Sell |
4,484
-1,768
| -28% | -$3.15K | ﹤0.01% | 4803 |
|
2022
Q2 | $12K | Buy |
6,252
+2,388
| +62% | +$4.58K | ﹤0.01% | 4300 |
|
2022
Q1 | $32K | Sell |
3,864
-6,149
| -61% | -$50.9K | ﹤0.01% | 3090 |
|
2021
Q4 | $73K | Buy |
+10,013
| New | +$73K | ﹤0.01% | 2459 |
|
2021
Q2 | – | Sell |
-3,249
| Closed | -$12K | – | 5779 |
|
2021
Q1 | $12K | Sell |
3,249
-3,061
| -49% | -$11.3K | ﹤0.01% | 4272 |
|
2020
Q4 | $19K | Sell |
6,310
-9,720
| -61% | -$29.3K | ﹤0.01% | 3904 |
|
2020
Q3 | $57K | Buy |
16,030
+12,557
| +362% | +$44.7K | ﹤0.01% | 3484 |
|
2020
Q2 | $15K | Buy |
+3,473
| New | +$15K | ﹤0.01% | 3824 |
|
2020
Q1 | – | Sell |
-7,690
| Closed | -$39K | – | 3753 |
|
2019
Q4 | $39K | Buy |
+7,690
| New | +$39K | ﹤0.01% | 1493 |
|
2019
Q3 | – | Sell |
-1,587
| Closed | -$8K | – | 4449 |
|
2019
Q2 | $8K | Buy |
1,587
+1,582
| +31,640% | +$7.98K | ﹤0.01% | 2706 |
|
2019
Q1 | $0 | Sell |
5
-18
| -78% | – | ﹤0.01% | 4193 |
|
2018
Q4 | $0 | Buy |
+23
| New | – | ﹤0.01% | 4263 |
|